Anhui Fengyuan Pharmaceutical Co., Ltd.

000153

CNE0000014X5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/06/2024 am IST			5-day change	1st Jan Change
5.54 ^CNY	-0.36%		-1.25%	-17.23%

30/05	Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024	CI
23/05	Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024

May 31, 2024 at 01:01 am IST

Anhui Fengyuan Pharmaceutical Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 1.50000000. Record date: 06 June 2024. Ex-date: 07 June 2024.

Payment date: 07 June 2024.

Latest news about Anhui Fengyuan Pharmaceutical Co., Ltd.

Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024	31/05	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	23/05	CI
Fengyuan Pharma Gets Nod to Register Two Dialysis Solutions	13/05	MT
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	27/04	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. canceled the acquisition of Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	20/23/20	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 16, 2023	10/23/10	CI
Anhui Fengyuan Pharmaceutical Announces Cash Dividend for 2022	20/23/20	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend (Tax Included) for 2022	21/23/21	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. agreed to acquire Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	08/23/08	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. announced a financing transaction	03/23/03	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire Anhui Fengyuan Gelatin Co., Ltd. from BBCA Group Co., Ltd. for approximately CNY 308 million.	12/22/12	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/22/24	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Management Appointments	09/22/09	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022	30/22/30	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Distribution for 2021	27/22/27	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	30/22/30	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

Duration

Period

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

More charts

Company Profile

ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, manufacture and distribution of biological medicines, chemical synthetic medicines and Chinese medicines. The Company's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The Company is also engaged in the retailing and wholesale of drugs. The Company conducts its businesses mainly in domestic markets, with Anhui province as its main market.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD.	-17.23%	355M
ELI LILLY AND COMPANY	+51.82%	797B
NOVO NORDISK A/S	+40.68%	628B
JOHNSON & JOHNSON	-6.88%	351B
MERCK & CO., INC.	+16.95%	323B
ABBVIE INC.	+9.49%	300B
ASTRAZENECA PLC	+17.02%	244B
ROCHE HOLDING AG	+0.90%	223B
AMGEN INC.	+5.30%	163B
PFIZER, INC.	-6.29%	153B